Insights

Gathering insights about SC…

Similar companies to SC

SC Tech Stack

SC uses 8 technology products and services including Fastly, WordPress, JSON-LD, and more. Explore SC's tech stack below.

Fastly
Content Delivery Network
WordPress
Content Management System
JSON-LD
Javascript Frameworks
Flywheel
Platform As A Service
reCAPTCHA
Security
Google Tag Manager
Tag Management
Contact Form 7
Web Platform Extensions
Apache
Web Servers

Media & News

Merck Receives Two Positive EU CHMP Opinions for KEYTRUDA® (pembrolizumab), for Subcutaneous (SC) Administration and for New Indication for Earlier-Stage Head and Neck Cancer
RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) adopted two positive opinions for KEYTRUDA® (pembrolizumab), Merck's anti-PD-1 therapy. One recommends approval of a new subcutaneous (SC) route of administration and a new pharmaceutical form (solution for injection) for KEYTRUDA® (pembrolizumab), which if approved would be marketed in.
Sep 19, 2025 | www.businesswire.com
Santander Consumer Launches Drive Together, Offering Dealers Pre-Qualified Leads from Web Traffic
DALLAS--(BUSINESS WIRE)--Santander Consumer USA Inc. (“Santander Consumer”) has launched Drive Together, a digital retail tool and expansion of Santander's Drive® offering that provides pre-qualification resources to support a broad range of customer and dealer needs. Drive Together is a subscription service for dealers that resides on car dealerships' websites, allowing dealers to generate pre-qualified leads from their web traffic. Santander's Drive® platform uses "soft" credit checks to preq.
Jul 08, 2025 | www.businesswire.com
TREMFYA® (guselkumab) subcutaneous (SC) induction data support potential to be the first and only in its class to offer the option of both intravenous and SC induction therapy in ulcerative colitis
Phase 3 ASTRO study achieves primary and all secondary endpoints at Week 12 in ulcerative colitis patients The only SC induction data for an IL-23 inhibitor show statistically significant and clinically meaningful improvements across clinical and endoscopic measures versus placebo, consistent with IV induction SPRING HOUSE, Pa. , Feb. 21, 2025 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced data from the Phase 3 ASTRO study of TREMFYA® (guselkumab) subcutaneous (SC) induction therapy in adults with moderately to severely active ulcerative colitis (UC) at the 20th Congress of the European Crohn's and Colitis Organization (ECCO).
Feb 21, 2025 | www.prnewswire.com
Telsey Advisory Group LLC announces U.S. Equity Research alliance with Santander
NEW YORK--(BUSINESS WIRE)--Telsey Advisory Group LLC (TAG) announced today that it has entered a strategic alliance with Santander's U.S. broker-dealer subsidiary Santander U.S. Capital Markets LLC. TAG is a recognized leader in the consumer sector, with an established track record, highly regarded analysts, and a clear vision for expansion. TAG, founded in 2006 by Dana Telsey, is a leading equity research firm, with a strong institutional equity sales and agency trading platform focused on the.
Dec 16, 2024 | www.businesswire.com
Celltrion presents 2-year post-hoc analysis findings for subcutaneous infliximab (CT-P13 SC), highlighting dose escalation as an option for managing loss of response in inflammatory bowel disease
INCHEON, South Korea--(BUSINESS WIRE)--Celltrion today announced two-year results of subcutaneous infliximab (CT-P13 SC) dose escalation therapy at United European Gastroenterology (UEG) Week 2024 in Vienna. The post-hoc analysis from the LIBERTY-CD (Crohn's disease) and LIBERTY-UC (ulcerative colitis) studies suggest that dose escalation of CT-P13 SC following intravenous (IV) induction in patients who initially respond but subsequently lose response, showed clinical efficacy over an extended.
Oct 15, 2024 | www.businesswire.com
Xeris Biopharma Announces Positive Topline Phase 2 Clinical Data of Its Investigational XeriSol™-Formulated Once-Weekly Subcutaneous (SC) Levothyroxine (XP-8121)
CHICAGO--(BUSINESS WIRE)-- #GvokeHypoPen--Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patients' lives by developing and commercializing innovative products across a range of therapies, today announced topline results from its recently completed Phase 2 multi-center, open label, study of XP-8121 for the treatment of adults with hypothyroidism. XP-8121 employs the Company's XeriSol™ formulation technology to enable a novel once-weekly SC injec.
May 30, 2024 | www.businesswire.com
U.S. FDA Approves Subcutaneous Administration of Takeda’s ENTYVIO® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Crohn’s Disease
− ENTYVIO is Now Available in the U.S. in Both IV and Subcutaneous Administrations for Maintenance Treatment of Adults with Moderately to Severely Active Ulcerative Colitis or Crohn’s Disease OSAKA, Japan & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance … The post U.S. FDA Approves Subcutaneous Administration of Takeda’s ENTYVIO® (vedo...
Apr 18, 2024 | www.headlinesoftoday.com

SC's Email Address Formats

SC uses at least 1 format(s):

SC Email Formats	Example	Percentage
FLast@servicecompression.com	JDoe@servicecompression.com	47%
First@servicecompression.com	John@servicecompression.com	3%
FLast@servicecompression.com	JDoe@servicecompression.com	47%
First@servicecompression.com	John@servicecompression.com	3%

Frequently Asked Questions

Where is SC's headquarters located?

SC's main headquarters is located at 3575 Lone Star Circle, Fort Worth, Texas 76177, US. The company has employees across 1 continents, including North America.

What is SC's stock symbol?

SC is a publicly traded company; the company's stock symbol is SC.

What is SC's official website and social media links?

SC's official website is servicecompression.com and has social profiles on LinkedIn Crunchbase.

What is SC's NAICS code?

SC's NAICS code is 211 - Oil and Gas Extraction.

How many employees does SC have currently?

As of October 2025, SC has approximately 73 employees across 1 continents, including North America. Key team members include Chief Executive Officer: R. N.Chief Investment Officer: J. L.Chief Legal Officer: J. K.. Explore SC's employee directory with LeadIQ.

What industry does SC belong to?

SC operates in the Oil and Gas industry.

What technology does SC use?

SC's tech stack includes FastlyWordPressJSON-LDFlywheelreCAPTCHAGoogle Tag ManagerContact Form 7Apache.

What is SC's email format?

SC's email format typically follows the pattern of FLast@servicecompression.com. Find more SC email formats with LeadIQ.

SC

Oil and GasUnited States51-200 Employees

SC is a leading provider of natural gas compression services for exploration and production companies that offers full-service compression solutions, including maintenance and optimization, to keep operations running smoothly and efficiently.

Company Overview

Headquarters: 3575 Lone Star Circle, Fort Worth, Texas 76177, US
Website: servicecompression.com
Stock Symbol: SC
NAICS Code: 211 - Oil and Gas Extraction
Employees: 51-200

Media & News

Funding & Financials

$100M$250M
SC's revenue is estimated to be in the range of $100M$250M

Funding & Financials

$100M$250M
SC's revenue is estimated to be in the range of $100M$250M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Insights

Similar companies to SC

Hotel Trundle

Florence

SC Tech Stack

Media & News

Merck Receives Two Positive EU CHMP Opinions for KEYTRUDA® (pembrolizumab), for Subcutaneous (SC) Administration and for New Indication for Earlier-Stage Head and Neck Cancer

Santander Consumer Launches Drive Together, Offering Dealers Pre-Qualified Leads from Web Traffic

TREMFYA® (guselkumab) subcutaneous (SC) induction data support potential to be the first and only in its class to offer the option of both intravenous and SC induction therapy in ulcerative colitis

Telsey Advisory Group LLC announces U.S. Equity Research alliance with Santander

Celltrion presents 2-year post-hoc analysis findings for subcutaneous infliximab (CT-P13 SC), highlighting dose escalation as an option for managing loss of response in inflammatory bowel disease

Xeris Biopharma Announces Positive Topline Phase 2 Clinical Data of Its Investigational XeriSol™-Formulated Once-Weekly Subcutaneous (SC) Levothyroxine (XP-8121)

U.S. FDA Approves Subcutaneous Administration of Takeda’s ENTYVIO® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Crohn’s Disease

SC's Email Address Formats

Frequently Asked Questions

Where is SC's headquarters located?

What is SC's stock symbol?

What is SC's official website and social media links?

What is SC's NAICS code?

How many employees does SC have currently?

What industry does SC belong to?

What technology does SC use?

What is SC's email format?

SC

Company Overview

Media & News

Merck Receives Two Positive EU CHMP Opinions for KEYTRUDA® (pembrolizumab), for Subcutaneous (SC) Administration and for New Indication for Earlier-Stage Head and Neck Cancer

Santander Consumer Launches Drive Together, Offering Dealers Pre-Qualified Leads from Web Traffic

TREMFYA® (guselkumab) subcutaneous (SC) induction data support potential to be the first and only in its class to offer the option of both intravenous and SC induction therapy in ulcerative colitis

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?